(Q43906664)

27 November 2017

title

Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes (English)

1 reference

27 November 2017

0 references

Cristina Monfardini

1

1 reference

27 November 2017

Monica Milani

2

1 reference

27 November 2017

Norma Ostlie

3

1 reference

27 November 2017

Wei Wang

4

1 reference

27 November 2017

Peter I Karachunski

5

1 reference

27 November 2017

David K Okita

6

1 reference

27 November 2017

Jon Lindstrom

7

1 reference

27 November 2017

Bianca M Conti-Fine

8

1 reference

27 November 2017

language of work or name

1 reference

1 February 2002

1 reference

Journal of Neuroimmunology

27 November 2017

published in

1 reference

27 November 2017

volume

123

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

123-134

1 reference

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Experimental myasthenia gravis. A murine system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Generation and analysis of interleukin-4 deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900454-4

7 January 2021

10.1016/S0165-5728(01)00454-4

Identifiers

DOI

1 reference

27 November 2017

1 reference